COVID-19: Will the government meet its next vaccine target? Here’s what the data suggests | UK News



[ad_1]

The coronavirus vaccine has been offered to everyone in the top four priority groups in the UK, the government said after meeting its initial target in launching the jab.

Prime Minister Boris Johnson had set a deadline of Monday February 15 to offer a first dose of the COVID-19 Vaccine for all nursing home residents and staff, all people over the age of 70, all NHS frontline and care staff, and those who are clinically extremely vulnerable.

After achieving that goal, the ministers have set themselves to offer the vaccine to all people over 50 years of age and all adults in risk groups, which number 32 million people, by May.

But how realistic is that goal?

More than 15 million people in the United Kingdom they have received a first dose since 8 December, making the jab launch in this country one of the fastest in the world.

Scroll down the table to see the vaccine implementation milestones so far.

December 8: Margaret Keenan, 90, becomes the first person in the world to receive the Pfizer – BioNTech vaccine, outside of clinical trials.

The following week, more than half a million people in the UK receive their first dose, but supply problems slow the pace for the rest of the month.

AstraZeneca’s easy-to-distribute vaccine launch begins January 4, leading to nearly three times the dose increase the following week.

In mid-January, health and social care workers start receiving their first doses in more than 1,000 locations across the UK.

2,532,381 doses are given in the seven days through January 24, the highest in a single week. Half of people over 80 have already received their first vaccination.

On February 15, the UK government says it has offered a vaccine to all members of the four main priority groups, achieving its goal. One in four adults has already received a first dose.

Although a first dose has been offered to everyone in the four highest priority groups, what proportion of people in the oldest age groups have received the vaccine?

The table below reveals the percentage of older age groups that have received a first dose of the COVID-19 vaccine in different regions of the UK as of 7 February, except Northern Ireland where data is not available. .

Figures are released weekly and data for the last week has yet to be released.

The government has now set a goal of offering a first dose of the vaccine to the 32 million people in the top nine priority groups by May.

This covers all people over the age of 50 and younger people considered clinically vulnerable.

But is it likely to meet that goal? We have considered three scenarios.

The government’s next goal is to deliver the first dose to another 17 million people by May, in time for local elections.

If vaccines continue at the current rate and second doses are given at 11 weeks, the 32 million people in the nine priority groups could receive a first dose as early as the end of March.

If the daily vaccination rate fell by about 5%, as it did in late January when the supply of Pfizer vaccine declined, then the target could be reached on April 4.

But if the addition of the Moderna vaccine helped increase the daily rate by a similar amount, 5%, the government could offer a first dose of vaccine to all 32 million people by March 25.

The analysis above has been calculated using the most recent 14-day daily vaccination rate and assumes that people requiring a second injection receive it at 11 weeks.

But they are just a few scenarios of how the government could reach its next goal.

There are many factors that could affect the progress of the launch, some beyond the control of minters, such as the supply of vaccines.

Disruption of production or distribution could slow down the process, but the addition of Moderna’s jab, which will be introduced before spring, could boost it.

The number of vaccination centers and staff are also limiting factors, prompting Labor Sir Keir Starmer to call for jabs to be recommended. “around the clock”.

If this happens, it could speed up the process considerably.

Finally, the timing of the second dose could have a significant impact.

If people who have already received a first dose do not receive the second for 12 weeks, it will relieve pressure on supply and distribution.

Similarly, if second doses were offered at 10 weeks, this could increase demand so much that the May deadline would become problematic.

Methodology: The daily dose rate between December 30 and January 10, for which no data is available, uses average doses derived from 1.6 million total doses assumed during the same period.

[ad_2]